Media

BIO Latin American Conference will bring together biotechnology executives, academics and investors from around the globe
Registration for this year’s Livestock Biotech Summit is officially open to attendees and credentialed media, the Biotechnology Industry Organization (...

Press Releases

Mar 26 2002
Washington, D.C. (March 26, 2002)- BIO President Carl B. Feldbaum today issued the following statement on President Bush’s nominations for NIH director,...
Mar 25 2002
WASHINGTON, D.C. (March 25, 2002) - The preview program for the BIO 2002 International Biotechnology Convention & Exhibition, including confirmed speakers...
Mar 16 2002
Washington, D.C. (March 16, 2002)- The deadline for on-line registration for those seeking media credentials for BIO 2002 in Toronto is Friday, May 24, 2002....
Mar 13 2002
Washington, D.C. (March 13, 2002)-The Biotechnology Industry Organization (BIO) announced today that discussions with the Food and Drug Administration and the...
Mar 12 2002
WASHINGTON, D.C. (March 12, 2002) - The Interoperable Informatics Infrastructure Consortium (I3C) which was incorporated on Feb. 13, 2002, held its first...
Mar 7 2002
WASHINGTON, D.C. (March 7, 2002) – The advance program for the BIO 2002 International Biotechnology Convention & Exhibition is available online at...
Mar 5 2002
March 5, 2002 (Washington, D.C.)-In conjunction with today’s hearing by the Senate Health, Education, Labor and Pensions Committee on “The Dangers...
Mar 5 2002
WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of...
Mar 4 2002
(WASHINGTON, DC) - March 4, 2002 - After a four-month delay, the Centers for Medicare and Medicaid Services (CMS) issued a corrected regulation on pass-through...


Biotechnology News

April 18, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that it granted...

April 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight...

April 18, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use...

April 18, 2014

WASHINGTON--(BUSINESS WIRE)--Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine; International leaders to share unparalleled achievements in stem...

April 18, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies...